Among IL-1 Inhibitors for Treating VEXAS, This One Stands Out

(MedPage Today) — Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome with an interleukin-1 (IL-1) inhibitor, a multinational study indicated.
Among 47 VEXAS patients treated…